Can antiarrhythmic drugs save lives in patients with congestive heart failure?

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Can antiarrhythmic drugs save lives in patients with congestive heart failure? / Brendorp, Bente; Pedersen, Ole Dyg; Elming, Hanne; Køber, Lars; Torp-Pedersen, Christian.

I: Expert Review of Cardiovascular Therapy, Bind 1, Nr. 2, 2003, s. 191-202.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Brendorp, B, Pedersen, OD, Elming, H, Køber, L & Torp-Pedersen, C 2003, 'Can antiarrhythmic drugs save lives in patients with congestive heart failure?', Expert Review of Cardiovascular Therapy, bind 1, nr. 2, s. 191-202. https://doi.org/10.1586/14779072.1.2.191

APA

Brendorp, B., Pedersen, O. D., Elming, H., Køber, L., & Torp-Pedersen, C. (2003). Can antiarrhythmic drugs save lives in patients with congestive heart failure? Expert Review of Cardiovascular Therapy, 1(2), 191-202. https://doi.org/10.1586/14779072.1.2.191

Vancouver

Brendorp B, Pedersen OD, Elming H, Køber L, Torp-Pedersen C. Can antiarrhythmic drugs save lives in patients with congestive heart failure? Expert Review of Cardiovascular Therapy. 2003;1(2):191-202. https://doi.org/10.1586/14779072.1.2.191

Author

Brendorp, Bente ; Pedersen, Ole Dyg ; Elming, Hanne ; Køber, Lars ; Torp-Pedersen, Christian. / Can antiarrhythmic drugs save lives in patients with congestive heart failure?. I: Expert Review of Cardiovascular Therapy. 2003 ; Bind 1, Nr. 2. s. 191-202.

Bibtex

@article{f4f6e8c0118c11df803f000ea68e967b,
title = "Can antiarrhythmic drugs save lives in patients with congestive heart failure?",
abstract = "Although arrhythmic death is a common cause of death in patients with congestive heart failure (CHF), numerous trials involving prophylactic antiarrhythmic drug treatment have yielded few gains. To date, only beta-blockers have shown a distinct mortality-reducing effect and despite the antiarrythmic effect of gamma-blockers, results point towards causes other than the antiarrhythmic effect in obtaining this beneficial effect. Atrial fibrillation is an often-encountered arrhythmia in patients with CHF and recent trials have cast doubt on the present treatment strategy of persistently striving to obtain sinus rhythm. This paper outlines the results of the large clinical trials dealing with antiarrhythmic drug treatment in CHF patients with or without atrial fibrillation and certain subgroup analysis and future treatment possibilities are discussed.",
author = "Bente Brendorp and Pedersen, {Ole Dyg} and Hanne Elming and Lars K{\o}ber and Christian Torp-Pedersen",
note = "Keywords: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Clinical Trials as Topic; Heart Failure; Humans; Risk Factors; Ventricular Dysfunction, Left",
year = "2003",
doi = "10.1586/14779072.1.2.191",
language = "English",
volume = "1",
pages = "191--202",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Taylor & Francis",
number = "2",

}

RIS

TY - JOUR

T1 - Can antiarrhythmic drugs save lives in patients with congestive heart failure?

AU - Brendorp, Bente

AU - Pedersen, Ole Dyg

AU - Elming, Hanne

AU - Køber, Lars

AU - Torp-Pedersen, Christian

N1 - Keywords: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Clinical Trials as Topic; Heart Failure; Humans; Risk Factors; Ventricular Dysfunction, Left

PY - 2003

Y1 - 2003

N2 - Although arrhythmic death is a common cause of death in patients with congestive heart failure (CHF), numerous trials involving prophylactic antiarrhythmic drug treatment have yielded few gains. To date, only beta-blockers have shown a distinct mortality-reducing effect and despite the antiarrythmic effect of gamma-blockers, results point towards causes other than the antiarrhythmic effect in obtaining this beneficial effect. Atrial fibrillation is an often-encountered arrhythmia in patients with CHF and recent trials have cast doubt on the present treatment strategy of persistently striving to obtain sinus rhythm. This paper outlines the results of the large clinical trials dealing with antiarrhythmic drug treatment in CHF patients with or without atrial fibrillation and certain subgroup analysis and future treatment possibilities are discussed.

AB - Although arrhythmic death is a common cause of death in patients with congestive heart failure (CHF), numerous trials involving prophylactic antiarrhythmic drug treatment have yielded few gains. To date, only beta-blockers have shown a distinct mortality-reducing effect and despite the antiarrythmic effect of gamma-blockers, results point towards causes other than the antiarrhythmic effect in obtaining this beneficial effect. Atrial fibrillation is an often-encountered arrhythmia in patients with CHF and recent trials have cast doubt on the present treatment strategy of persistently striving to obtain sinus rhythm. This paper outlines the results of the large clinical trials dealing with antiarrhythmic drug treatment in CHF patients with or without atrial fibrillation and certain subgroup analysis and future treatment possibilities are discussed.

U2 - 10.1586/14779072.1.2.191

DO - 10.1586/14779072.1.2.191

M3 - Journal article

C2 - 15030280

VL - 1

SP - 191

EP - 202

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 2

ER -

ID: 17397163